SEC Form D · filed March 16, 2018
Navitor Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Rick P. Lundberg · Cambridge, MAExecKevin P. Bitterman · Cambridge, MADirectorDavid P. Madden · Cambridge, MADirectorGeorge P. Vlasuk · Cambridge, MAExec · DirectorJohn P. Creecy · Cambridge, MADirectorMarian P. Nakada, Ph.D · Cambridge, MADirectorAlan P. Crane · Cambridge, MADirectorVinzenz P. Ploerer · Cambridge, MADirectorJonathan Neiss · NEW YORK, NYDirectorDonald E. Conrad · Islandia, NYDirectorSeth Lax · NEW YORK, NYExec · DirectorEkta S. Dang · Fremont, CADirectorMelissa S. Miller · North Charleston, SCDirectorDavid Icikson · New York, NYExecAaron Katz · New York, NYDirectorCatenary Carbon GP, LLC · Miami, FLDirectorBrian P. Gallagher, Ph.D · Cambridge, MADirectorPaul P. Friedman, M.D · Cambridge, MADirectorBrenda Smith · Conshohocken, PAExecPawel Gierynski · Warsaw, R9DirectorStephen Richmond · Warsaw, R9DirectorNeil Milne · Warsaw, R9Exec · DirectorWilliam Manby · Akron, OHDirectorTullis Growth Partners Ii, L.L.C · PALM BEACH GARDENS, FLDirectorWilliam Warren · Lorton, VADirectorThomas L. Tuttle · New York, NYDirectorBrian P. Gallagher, Ph.D · Cambridge, MADirectorPaul P. Friedman, M.D · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗